Sound Income Strategies’s Plus Therapeutics PSTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1
Closed -$4 1904
2026
Q1
$4 Hold
1
﹤0.01% 2589
2025
Q4
$8 Buy
+1
New +$15 ﹤0.01% 2507

Other funds holding PSTV

Sound Income Strategies's PSTV Position: Q2 2026 in Review

Sound Income Strategies sold out of Plus Therapeutics (PSTV) in Q2 2026, closing a stake of 1 share — an estimated $4 sold.

Sound Income Strategies first reported a position in PSTV in Q4 2025 and held it in 2 quarters. The position peaked at $8 in Q4 2025. 2 funds tracked by Wall St. Rank hold PSTV as of Q2 2026.

  • Sound Income Strategies reported no remaining Plus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 1 Plus Therapeutics share in Q2 2026, an estimated $4.
  • Sound Income Strategies first reported a position in Plus Therapeutics in Q4 2025 and held it in 2 quarters.
  • Sound Income Strategies's Plus Therapeutics position peaked at $8 in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Plus Therapeutics as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.